1 Study Coverage
    1.1 Autoimmune Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Autoimmune Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Rheumatoid Arthritis (RA)
        1.2.3 Multiple Sclerosis (MS)
        1.2.4 Psoriasis
        1.2.5 Inflammatory Bowel Disease (IBD)
        1.2.6 Ankylosing Spondylitis (AS)
        1.2.7 Systemic Lupus Erythematosus (SLE)
    1.3 Market by Application
        1.3.1 Global Autoimmune Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Homecare
        1.3.4 Specialty Clinics
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Autoimmune Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Autoimmune Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Autoimmune Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Autoimmune Drugs Sales by Region
        2.4.1 Global Autoimmune Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Autoimmune Drugs by Region (2023-2028)
    2.5 Global Autoimmune Drugs Revenue by Region
        2.5.1 Global Autoimmune Drugs Revenue by Region (2017-2022)
        2.5.2 Global Autoimmune Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Autoimmune Drugs Sales by Manufacturers
        3.1.1 Global Top Autoimmune Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Autoimmune Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Autoimmune Drugs in 2021
    3.2 Global Autoimmune Drugs Revenue by Manufacturers
        3.2.1 Global Autoimmune Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Autoimmune Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Autoimmune Drugs Revenue in 2021
    3.3 Global Autoimmune Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Autoimmune Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Autoimmune Drugs Sales by Type
        4.1.1 Global Autoimmune Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Autoimmune Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Autoimmune Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Autoimmune Drugs Revenue by Type
        4.2.1 Global Autoimmune Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Autoimmune Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Autoimmune Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Autoimmune Drugs Price by Type
        4.3.1 Global Autoimmune Drugs Price by Type (2017-2022)
        4.3.2 Global Autoimmune Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Autoimmune Drugs Sales by Application
        5.1.1 Global Autoimmune Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Autoimmune Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Autoimmune Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Autoimmune Drugs Revenue by Application
        5.2.1 Global Autoimmune Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Autoimmune Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Autoimmune Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Autoimmune Drugs Price by Application
        5.3.1 Global Autoimmune Drugs Price by Application (2017-2022)
        5.3.2 Global Autoimmune Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Autoimmune Drugs Market Size by Type
        6.1.1 North America Autoimmune Drugs Sales by Type (2017-2028)
        6.1.2 North America Autoimmune Drugs Revenue by Type (2017-2028)
    6.2 North America Autoimmune Drugs Market Size by Application
        6.2.1 North America Autoimmune Drugs Sales by Application (2017-2028)
        6.2.2 North America Autoimmune Drugs Revenue by Application (2017-2028)
    6.3 North America Autoimmune Drugs Market Size by Country
        6.3.1 North America Autoimmune Drugs Sales by Country (2017-2028)
        6.3.2 North America Autoimmune Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Autoimmune Drugs Market Size by Type
        7.1.1 Europe Autoimmune Drugs Sales by Type (2017-2028)
        7.1.2 Europe Autoimmune Drugs Revenue by Type (2017-2028)
    7.2 Europe Autoimmune Drugs Market Size by Application
        7.2.1 Europe Autoimmune Drugs Sales by Application (2017-2028)
        7.2.2 Europe Autoimmune Drugs Revenue by Application (2017-2028)
    7.3 Europe Autoimmune Drugs Market Size by Country
        7.3.1 Europe Autoimmune Drugs Sales by Country (2017-2028)
        7.3.2 Europe Autoimmune Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Autoimmune Drugs Market Size by Type
        8.1.1 Asia Pacific Autoimmune Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Autoimmune Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Autoimmune Drugs Market Size by Application
        8.2.1 Asia Pacific Autoimmune Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Autoimmune Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Autoimmune Drugs Market Size by Region
        8.3.1 Asia Pacific Autoimmune Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Autoimmune Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Autoimmune Drugs Market Size by Type
        9.1.1 Latin America Autoimmune Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Autoimmune Drugs Revenue by Type (2017-2028)
    9.2 Latin America Autoimmune Drugs Market Size by Application
        9.2.1 Latin America Autoimmune Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Autoimmune Drugs Revenue by Application (2017-2028)
    9.3 Latin America Autoimmune Drugs Market Size by Country
        9.3.1 Latin America Autoimmune Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Autoimmune Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Autoimmune Drugs Market Size by Type
        10.1.1 Middle East and Africa Autoimmune Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Autoimmune Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Autoimmune Drugs Market Size by Application
        10.2.1 Middle East and Africa Autoimmune Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Autoimmune Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Autoimmune Drugs Market Size by Country
        10.3.1 Middle East and Africa Autoimmune Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Autoimmune Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Corporation Information
        11.1.2 Eli Lilly Overview
        11.1.3 Eli Lilly Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Eli Lilly Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Eli Lilly Recent Developments
    11.2 GSK
        11.2.1 GSK Corporation Information
        11.2.2 GSK Overview
        11.2.3 GSK Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GSK Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GSK Recent Developments
    11.3 AbbVie
        11.3.1 AbbVie Corporation Information
        11.3.2 AbbVie Overview
        11.3.3 AbbVie Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 AbbVie Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 AbbVie Recent Developments
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Corporation Information
        11.4.2 Johnson & Johnson Overview
        11.4.3 Johnson & Johnson Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Johnson & Johnson Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Johnson & Johnson Recent Developments
    11.5 Biogen
        11.5.1 Biogen Corporation Information
        11.5.2 Biogen Overview
        11.5.3 Biogen Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Biogen Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Biogen Recent Developments
    11.6 Amgen
        11.6.1 Amgen Corporation Information
        11.6.2 Amgen Overview
        11.6.3 Amgen Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Amgen Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Amgen Recent Developments
    11.7 Pfizer
        11.7.1 Pfizer Corporation Information
        11.7.2 Pfizer Overview
        11.7.3 Pfizer Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Pfizer Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Pfizer Recent Developments
    11.8 Roche
        11.8.1 Roche Corporation Information
        11.8.2 Roche Overview
        11.8.3 Roche Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Roche Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Roche Recent Developments
    11.9 Baxter
        11.9.1 Baxter Corporation Information
        11.9.2 Baxter Overview
        11.9.3 Baxter Autoimmune Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Baxter Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Baxter Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Autoimmune Drugs Industry Chain Analysis
    12.2 Autoimmune Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Autoimmune Drugs Production Mode & Process
    12.4 Autoimmune Drugs Sales and Marketing
        12.4.1 Autoimmune Drugs Sales Channels
        12.4.2 Autoimmune Drugs Distributors
    12.5 Autoimmune Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Autoimmune Drugs Industry Trends
    13.2 Autoimmune Drugs Market Drivers
    13.3 Autoimmune Drugs Market Challenges
    13.4 Autoimmune Drugs Market Restraints
14 Key Findings in The Global Autoimmune Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Autoimmune Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Rheumatoid Arthritis (RA)
    Table 3. Major Manufacturers of Multiple Sclerosis (MS)
    Table 4. Major Manufacturers of Psoriasis
    Table 5. Major Manufacturers of Inflammatory Bowel Disease (IBD)
    Table 6. Major Manufacturers of Ankylosing Spondylitis (AS)
    Table 7. Major Manufacturers of Systemic Lupus Erythematosus (SLE)
    Table 8. Global Autoimmune Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Autoimmune Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Autoimmune Drugs Sales by Region (2017-2022) & (K Units)
    Table 11. Global Autoimmune Drugs Sales Market Share by Region (2017-2022)
    Table 12. Global Autoimmune Drugs Sales by Region (2023-2028) & (K Units)
    Table 13. Global Autoimmune Drugs Sales Market Share by Region (2023-2028)
    Table 14. Global Autoimmune Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Autoimmune Drugs Revenue Market Share by Region (2017-2022)
    Table 16. Global Autoimmune Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 17. Global Autoimmune Drugs Revenue Market Share by Region (2023-2028)
    Table 18. Global Autoimmune Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 19. Global Autoimmune Drugs Sales Share by Manufacturers (2017-2022)
    Table 20. Global Autoimmune Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 21. Global Autoimmune Drugs Revenue Share by Manufacturers (2017-2022)
    Table 22. Autoimmune Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 23. Global Autoimmune Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Autoimmune Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Drugs as of 2021)
    Table 25. Autoimmune Drugs Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Autoimmune Drugs Product Offered
    Table 27. Date of Manufacturers Enter into Autoimmune Drugs Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Autoimmune Drugs Sales by Type (2017-2022) & (K Units)
    Table 30. Global Autoimmune Drugs Sales by Type (2023-2028) & (K Units)
    Table 31. Global Autoimmune Drugs Sales Share by Type (2017-2022)
    Table 32. Global Autoimmune Drugs Sales Share by Type (2023-2028)
    Table 33. Global Autoimmune Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Global Autoimmune Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Global Autoimmune Drugs Revenue Share by Type (2017-2022)
    Table 36. Global Autoimmune Drugs Revenue Share by Type (2023-2028)
    Table 37. Autoimmune Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 38. Global Autoimmune Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 39. Global Autoimmune Drugs Sales by Application (2017-2022) & (K Units)
    Table 40. Global Autoimmune Drugs Sales by Application (2023-2028) & (K Units)
    Table 41. Global Autoimmune Drugs Sales Share by Application (2017-2022)
    Table 42. Global Autoimmune Drugs Sales Share by Application (2023-2028)
    Table 43. Global Autoimmune Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 44. Global Autoimmune Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 45. Global Autoimmune Drugs Revenue Share by Application (2017-2022)
    Table 46. Global Autoimmune Drugs Revenue Share by Application (2023-2028)
    Table 47. Autoimmune Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 48. Global Autoimmune Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 49. North America Autoimmune Drugs Sales by Type (2017-2022) & (K Units)
    Table 50. North America Autoimmune Drugs Sales by Type (2023-2028) & (K Units)
    Table 51. North America Autoimmune Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 52. North America Autoimmune Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 53. North America Autoimmune Drugs Sales by Application (2017-2022) & (K Units)
    Table 54. North America Autoimmune Drugs Sales by Application (2023-2028) & (K Units)
    Table 55. North America Autoimmune Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 56. North America Autoimmune Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 57. North America Autoimmune Drugs Sales by Country (2017-2022) & (K Units)
    Table 58. North America Autoimmune Drugs Sales by Country (2023-2028) & (K Units)
    Table 59. North America Autoimmune Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 60. North America Autoimmune Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Europe Autoimmune Drugs Sales by Type (2017-2022) & (K Units)
    Table 62. Europe Autoimmune Drugs Sales by Type (2023-2028) & (K Units)
    Table 63. Europe Autoimmune Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 64. Europe Autoimmune Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 65. Europe Autoimmune Drugs Sales by Application (2017-2022) & (K Units)
    Table 66. Europe Autoimmune Drugs Sales by Application (2023-2028) & (K Units)
    Table 67. Europe Autoimmune Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 68. Europe Autoimmune Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 69. Europe Autoimmune Drugs Sales by Country (2017-2022) & (K Units)
    Table 70. Europe Autoimmune Drugs Sales by Country (2023-2028) & (K Units)
    Table 71. Europe Autoimmune Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 72. Europe Autoimmune Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Autoimmune Drugs Sales by Type (2017-2022) & (K Units)
    Table 74. Asia Pacific Autoimmune Drugs Sales by Type (2023-2028) & (K Units)
    Table 75. Asia Pacific Autoimmune Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Autoimmune Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Autoimmune Drugs Sales by Application (2017-2022) & (K Units)
    Table 78. Asia Pacific Autoimmune Drugs Sales by Application (2023-2028) & (K Units)
    Table 79. Asia Pacific Autoimmune Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Autoimmune Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Autoimmune Drugs Sales by Region (2017-2022) & (K Units)
    Table 82. Asia Pacific Autoimmune Drugs Sales by Region (2023-2028) & (K Units)
    Table 83. Asia Pacific Autoimmune Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Autoimmune Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 85. Latin America Autoimmune Drugs Sales by Type (2017-2022) & (K Units)
    Table 86. Latin America Autoimmune Drugs Sales by Type (2023-2028) & (K Units)
    Table 87. Latin America Autoimmune Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Latin America Autoimmune Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 89. Latin America Autoimmune Drugs Sales by Application (2017-2022) & (K Units)
    Table 90. Latin America Autoimmune Drugs Sales by Application (2023-2028) & (K Units)
    Table 91. Latin America Autoimmune Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 92. Latin America Autoimmune Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 93. Latin America Autoimmune Drugs Sales by Country (2017-2022) & (K Units)
    Table 94. Latin America Autoimmune Drugs Sales by Country (2023-2028) & (K Units)
    Table 95. Latin America Autoimmune Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 96. Latin America Autoimmune Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Autoimmune Drugs Sales by Type (2017-2022) & (K Units)
    Table 98. Middle East and Africa Autoimmune Drugs Sales by Type (2023-2028) & (K Units)
    Table 99. Middle East and Africa Autoimmune Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Autoimmune Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Autoimmune Drugs Sales by Application (2017-2022) & (K Units)
    Table 102. Middle East and Africa Autoimmune Drugs Sales by Application (2023-2028) & (K Units)
    Table 103. Middle East and Africa Autoimmune Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Autoimmune Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Autoimmune Drugs Sales by Country (2017-2022) & (K Units)
    Table 106. Middle East and Africa Autoimmune Drugs Sales by Country (2023-2028) & (K Units)
    Table 107. Middle East and Africa Autoimmune Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Autoimmune Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 109. Eli Lilly Corporation Information
    Table 110. Eli Lilly Description and Major Businesses
    Table 111. Eli Lilly Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. Eli Lilly Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Eli Lilly Recent Developments
    Table 114. GSK Corporation Information
    Table 115. GSK Description and Major Businesses
    Table 116. GSK Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. GSK Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. GSK Recent Developments
    Table 119. AbbVie Corporation Information
    Table 120. AbbVie Description and Major Businesses
    Table 121. AbbVie Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. AbbVie Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. AbbVie Recent Developments
    Table 124. Johnson & Johnson Corporation Information
    Table 125. Johnson & Johnson Description and Major Businesses
    Table 126. Johnson & Johnson Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. Johnson & Johnson Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Johnson & Johnson Recent Developments
    Table 129. Biogen Corporation Information
    Table 130. Biogen Description and Major Businesses
    Table 131. Biogen Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. Biogen Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Biogen Recent Developments
    Table 134. Amgen Corporation Information
    Table 135. Amgen Description and Major Businesses
    Table 136. Amgen Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 137. Amgen Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Amgen Recent Developments
    Table 139. Pfizer Corporation Information
    Table 140. Pfizer Description and Major Businesses
    Table 141. Pfizer Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 142. Pfizer Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Pfizer Recent Developments
    Table 144. Roche Corporation Information
    Table 145. Roche Description and Major Businesses
    Table 146. Roche Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 147. Roche Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Roche Recent Developments
    Table 149. Baxter Corporation Information
    Table 150. Baxter Description and Major Businesses
    Table 151. Baxter Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 152. Baxter Autoimmune Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Baxter Recent Developments
    Table 154. Key Raw Materials Lists
    Table 155. Raw Materials Key Suppliers Lists
    Table 156. Autoimmune Drugs Distributors List
    Table 157. Autoimmune Drugs Customers List
    Table 158. Autoimmune Drugs Market Trends
    Table 159. Autoimmune Drugs Market Drivers
    Table 160. Autoimmune Drugs Market Challenges
    Table 161. Autoimmune Drugs Market Restraints
    Table 162. Research Programs/Design for This Report
    Table 163. Key Data Information from Secondary Sources
    Table 164. Key Data Information from Primary Sources
List of Figures
    Figure 1. Autoimmune Drugs Product Picture
    Figure 3. Global Autoimmune Drugs Market Share by Type in 2021 & 2028
    Figure 3. Rheumatoid Arthritis (RA) Product Picture
    Figure 4. Multiple Sclerosis (MS) Product Picture
    Figure 5. Psoriasis Product Picture
    Figure 6. Inflammatory Bowel Disease (IBD) Product Picture
    Figure 7. Ankylosing Spondylitis (AS) Product Picture
    Figure 8. Systemic Lupus Erythematosus (SLE) Product Picture
    Figure 9. Global Autoimmune Drugs Market Share by Application in 2021 & 2028
    Figure 10. Hospitals
    Figure 11. Homecare
    Figure 12. Specialty Clinics
    Figure 13. Autoimmune Drugs Report Years Considered
    Figure 14. Global Autoimmune Drugs Sales 2017-2028 (K Units)
    Figure 15. Global Autoimmune Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Autoimmune Drugs Revenue 2017-2028 (US$ Million)
    Figure 17. Global Autoimmune Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Autoimmune Drugs Sales Market Share by Region (2017-2022)
    Figure 19. Global Autoimmune Drugs Sales Market Share by Region (2023-2028)
    Figure 20. North America Autoimmune Drugs Sales YoY (2017-2028) & (K Units)
    Figure 21. North America Autoimmune Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Autoimmune Drugs Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe Autoimmune Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Autoimmune Drugs Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific Autoimmune Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Autoimmune Drugs Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America Autoimmune Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Autoimmune Drugs Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa Autoimmune Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Autoimmune Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Autoimmune Drugs in the World: Market Share by Autoimmune Drugs Revenue in 2021
    Figure 32. Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Autoimmune Drugs Sales Market Share by Type (2017-2028)
    Figure 34. Global Autoimmune Drugs Revenue Market Share by Type (2017-2028)
    Figure 35. Global Autoimmune Drugs Sales Market Share by Application (2017-2028)
    Figure 36. Global Autoimmune Drugs Revenue Market Share by Application (2017-2028)
    Figure 37. North America Autoimmune Drugs Sales Market Share by Type (2017-2028)
    Figure 38. North America Autoimmune Drugs Revenue Market Share by Type (2017-2028)
    Figure 39. North America Autoimmune Drugs Sales Market Share by Application (2017-2028)
    Figure 40. North America Autoimmune Drugs Revenue Market Share by Application (2017-2028)
    Figure 41. North America Autoimmune Drugs Sales Share by Country (2017-2028)
    Figure 42. North America Autoimmune Drugs Revenue Share by Country (2017-2028)
    Figure 43. U.S. Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Autoimmune Drugs Sales Market Share by Type (2017-2028)
    Figure 46. Europe Autoimmune Drugs Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Autoimmune Drugs Sales Market Share by Application (2017-2028)
    Figure 48. Europe Autoimmune Drugs Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Autoimmune Drugs Sales Share by Country (2017-2028)
    Figure 50. Europe Autoimmune Drugs Revenue Share by Country (2017-2028)
    Figure 51. Germany Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. France Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Autoimmune Drugs Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Autoimmune Drugs Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Autoimmune Drugs Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Autoimmune Drugs Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Autoimmune Drugs Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Autoimmune Drugs Revenue Share by Region (2017-2028)
    Figure 62. China Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. India Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Autoimmune Drugs Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Autoimmune Drugs Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Autoimmune Drugs Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Autoimmune Drugs Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Autoimmune Drugs Sales Share by Country (2017-2028)
    Figure 77. Latin America Autoimmune Drugs Revenue Share by Country (2017-2028)
    Figure 78. Mexico Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Autoimmune Drugs Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Autoimmune Drugs Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Autoimmune Drugs Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Autoimmune Drugs Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Autoimmune Drugs Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Autoimmune Drugs Revenue Share by Country (2017-2028)
    Figure 87. Turkey Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
    Figure 90. Autoimmune Drugs Value Chain
    Figure 91. Autoimmune Drugs Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed